Skip to main
MDLN

Medline Inc (MDLN) Earnings Dates & Reports

Medline Inc (MDLN) Most Recent Earnings

Report Date
Period EndingQ4 2025
Est. EPS$0.24
Actual EPS-$0.01
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Medline Inc (MDLN) Earnings per Share (EPS) History

Signup for full access
Browse free

Medline Inc (MDLN) Latest Earnings

The value each MDLN share was expected to gain vs. the value each share gained.

Medline Inc (MDLN) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$0.01. This exceeded analysts' expectations of $0.24 by 104.17%, marking a Miss.

For comparison, Medline Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.29.

Medline Inc (MDLN) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2026
$0.29
Q4 2025
$0.24-$0.01-104.17%

Medline Inc (MDLN) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Medline Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Medline Inc (MDLN) Earnings FAQs

Medline Inc (MDLN) last reported earnings on Feb 25, 2026 for Q4 2025, posting an EPS of -$0.01, which Miss the estimate of $0.24 by 104.17%.

For Q4 2025, Medline Inc (MDLN) reported an EPS of -$0.01, missing analysts' estimate of $0.24 by 104.17%.

For Q4 2025, Medline Inc (MDLN) Miss expectations with an actual EPS of -$0.01 vs. an estimated EPS of $0.24.

Following the last earnings report on Feb 25, 2026, Medline Inc (MDLN)'s stock price moved — from — to —.

The next Medline Inc (MDLN) earnings call is scheduled for Aug. 18, 2026, where executives will discuss financial results and outlook.

Medline Inc (MDLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.